Molecular roles of CDK5 in pain signaling

Ended Purchase Order Awarded Last action

Contract number
HHSN268201600060P
Awardee
Awarding agency
Obligated
$149,300

Award facts

Opportunity
Contract value 100% obligated
$149,300.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541690 Other Scientific and Technical Consulting Services
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92109, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Heart Lung and Blood Institute awarded a purchase order to Anabios Corp for $149,300 on August 15, 2016, for molecular roles of CDK5 in pain signaling research, with ultimate completion on August 14, 2019. Work is performed in San Diego, California. The order is firm fixed price with no small business set-aside. Anabios provides human-based testing services and specialized bioassay data to support drug development and safety evaluation, leveraging human primary cell models including dorsal root ganglia samples relevant to pain research mechanisms.

Quick answers

Who was awarded contract HHSN268201600060P?

HHSN268201600060P was awarded to Anabios Corp by National Heart Lung and Blood Institute (National Institutes of Health) on August 15, 2016.

How much is contract HHSN268201600060P worth?

The government has obligated $149,300 on HHSN268201600060P.

Was contract HHSN268201600060P competed?

The extent of competition for HHSN268201600060P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login